Trials / Completed
CompletedNCT01634282
Along-term Study of OPC-262 in Patients With Type 2 Diabetes
A Long-term Clinical Study of OPC-262 in Patients With Type 2 Diabetes on Study (Extension From Study 262-09-001)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 222 (actual)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical study is to evaluate the safety of OPC-262 (2.5 mg and 5 mg) in patients with type 2 diabetes by long-term administration orally for 52 weeks and to evaluate the efficacy of OPC-262
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OPC-262 | Orally administered once daily |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2012-07-06
- Last updated
- 2014-01-08
Locations
7 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01634282. Inclusion in this directory is not an endorsement.